키니네(Quinine) 시장 보고서(2025년)
Quinine Global Market Report 2025
상품코드 : 1769727
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 175 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,661,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,629,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,596,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

키니네 시장 규모는 향후 수 년간 강력한 성장이 전망될 예정입니다. 전통적인 의료행위에 대한 지지의 높아짐, 자연건강법에 대한 의식의 높아짐에 의해 촉진됩니다. 이 기간에 예상되는 주목할 만한 동향에는 합성 대체약의 진보, 드러그 전달 기술의 진보, 말라리아 치료 전략의 갱신, 병용 약물 치료에의 키니네의 임베디드, 키니네를 포함하지 않는 제제의 개발 등이 있습니다.

말라리아의 유병률 증가는 향후 몇 년 동안 키니네 시장의 성장을 가속할 것으로 예측됩니다. 말라리아 환자 증가는 세계적인 기온 상승과 관련이 있으며, 기온이 상승하면 이러한 모기의 서식지와 번식기가 확대됩니다. 기생충이 적혈구의 헤모글로빈을 소화하는 능력을 저해하고 기생충의 성장과 생존을 방해하여 말라리아와 싸웁니다. 영국에서 확인된 말라리아 환자는 2,004명으로 2022년 1,369명에서 증가했다고 보고했습니다.

키니네 시장에서 사업을 전개하는 기업은 생산 공정을 합리화하기 위해 키니네와 그 유도체의 고급 합성법의 개발에 주력하고 있습니다. 시간을 최소화하고 낭비를 없애고 비용을 절감하는 것을 목표로 합니다. 키니네 황산염의 실험실 기반 합성은 신초나 나무 껍질에서 자연적으로 추출하는 것을 모방하여 말라리아 치료에 사용되는 대규모 생산을 가능하게 합니다. 예를 들어, 2022년 12월, 일본의 도호쿠 대학의 연구자들은 키니네의 고효율인 에난치오 선택적 합성에 성공했습니다. 그들의 연구는 유기 촉매를 사용한 원팟 합성 방법을 도입하여 절차적 단계의 수를 줄였습니다. 이 기술 혁신은 화학 폐기물을 크게 줄이고 생산 시간을 단축하고 비용을 절감 할 수 있으므로 신약 개발을 촉진하고 전반적인 합성 효율을 향상시킵니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

SHW
영문 목차

영문목차

Quinine is a naturally occurring compound sourced from the bark of the cinchona tree and has been traditionally employed in the treatment of malaria. Its mechanism of action involves disrupting the growth and reproduction of the malaria parasite within red blood cells. Besides its pharmaceutical application, quinine is also an ingredient in tonic water, contributing to its signature bitter flavor. Although effective, quinine is associated with potential side effects and has often been replaced by newer antimalarial medications.

The primary products derived from quinine include quinine sulphate, quinine hydrochloride, quinine gluconate, and quinine bisulphate. Quinine sulfate, extracted from the cinchona tree, is predominantly used to treat malaria and, in some cases, nocturnal leg cramps. It is available in various forms of administration such as oral, intramuscular, intravenous, and others. Its range of applications covers malaria treatment, alleviation of nocturnal leg cramps, muscle pain, and restless leg syndrome. The key end users include hospitals, clinics, ambulatory surgical centers, and other healthcare facilities.

The quinine market research report is one of a series of new reports from The Business Research Company that provides quinine market statistics, including the quinine industry's global market size, regional shares, competitors with the quinine market share, detailed quinine market segments, market trends and opportunities, and any further data you may need to thrive in the quinine market. This quinine market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The quinine market size has grown strongly in recent years. It will grow from $2.25 billion in 2024 to $2.45 billion in 2025 at a compound annual growth rate (CAGR) of 9.2%. The expansion in previous years was driven by rising malaria cases in tropical zones, increased reliance on conventional antimalarial treatments, enhanced botanical research along colonial trade paths, greater health consciousness in developing nations, and heightened interest in herbal medicines.

The quinine market size is expected to see strong growth in the next few years. It will grow to $3.46 billion in 2029 at a compound annual growth rate (CAGR) of 9.0%. This projected growth will be fueled by growing resistance to synthetic malaria medications, rising acceptance of quinine in homeopathy and alternative treatments, increasing demand for economical malaria remedies, growing traction for traditional medicine practices, and heightened awareness of natural health solutions. Notable trends anticipated in this period include advancements in synthetic substitutes, progress in drug delivery techniques, updates in malaria care strategies, inclusion of quinine in combination drug therapies, and development of formulations that exclude quinine.

The increasing prevalence of malaria is anticipated to drive the growth of the quinine market in the coming years. Malaria, an infectious disease caused by Plasmodium parasites, is transmitted to humans through the bites of infected female Anopheles mosquitoes. The rise in malaria cases is linked to global temperature increases, which expand the habitat range and breeding season of these mosquitoes. Quinine, a powerful antimalarial drug, combats malaria by disrupting the parasite's ability to digest hemoglobin in red blood cells, thereby hindering its growth and survival. For example, in April 2024, the UK Health Security Agency reported 2,004 confirmed malaria cases in England in 2023, an increase from 1,369 in 2022. This surge in malaria cases is contributing to the growing demand for quinine.

Companies operating in the quinine market are focusing on developing advanced methods for synthesizing quinine and its derivatives to streamline production processes. These innovations aim to minimize time, reduce waste, and cut costs while improving the overall efficiency of chemical synthesis. The laboratory-based synthesis of quinine sulfate mimics its natural extraction from the bark of cinchona trees, allowing for large-scale production used in malaria treatment. For instance, in December 2022, researchers at Tohoku University in Japan achieved a highly efficient enantioselective synthesis of quinine. Their work introduced a one-pot synthesis method using organocatalysts, reducing the number of procedural steps. This innovation significantly lowers chemical waste, shortens production time, and potentially reduces costs, enhancing the development of new drugs and improving overall synthesis efficiency.

In June 2023, AlphaTalents Africa, an investment company based in Africa, acquired a controlling interest in Pharmakina for an undisclosed sum. The acquisition aims to enhance local production of quinine-based drugs, support local communities, and promote sustainable development in the Democratic Republic of the Congo. Pharmakina SA is a pharmaceutical company located in Africa that specializes in manufacturing quinine.

Major players in the quinine market are Teva Pharmaceutical Industries Ltd., Schweppes Australia Proprietary Limited, The United States Pharmacopeial Convention Inc., Chempro Pharma Private Limited, Taj Pharmaceuticals Ltd., Swiss Parenterals Private Limited, Leocorno Enterprises Private Limited, Healthy Inc., Jai Radhe Sales, Adooq Bioscience LLC, Akhil Healthcare Pvt Ltd., Van Wankum Ingredients B.V., Shreeji Pharma International, Prism Industries Private Limited, Lavina Pharmaceuticals Pvt Ltd., A. B. Enterprises, Spark Lifesciences Private Limited, Sihauli Chemicals Private Limited, Shanghai Nianxing Industrial Co. Ltd., and Sakhiya Pharma Chem.

North America was the largest region in the quinine market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in quinine report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the quinine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The quinine market consists of sales of products including topical ointments, bisulfate capsules, tonic water, and nutraceuticals. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Quinine Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on quinine market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for quinine ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The quinine market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Quinine Market Characteristics

3. Quinine Market Trends And Strategies

4. Quinine Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Quinine Growth Analysis And Strategic Analysis Framework

6. Quinine Market Segmentation

7. Quinine Market Regional And Country Analysis

8. Asia-Pacific Quinine Market

9. China Quinine Market

10. India Quinine Market

11. Japan Quinine Market

12. Australia Quinine Market

13. Indonesia Quinine Market

14. South Korea Quinine Market

15. Western Europe Quinine Market

16. UK Quinine Market

17. Germany Quinine Market

18. France Quinine Market

19. Italy Quinine Market

20. Spain Quinine Market

21. Eastern Europe Quinine Market

22. Russia Quinine Market

23. North America Quinine Market

24. USA Quinine Market

25. Canada Quinine Market

26. South America Quinine Market

27. Brazil Quinine Market

28. Middle East Quinine Market

29. Africa Quinine Market

30. Quinine Market Competitive Landscape And Company Profiles

31. Quinine Market Other Major And Innovative Companies

32. Global Quinine Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Quinine Market

34. Recent Developments In The Quinine Market

35. Quinine Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기